Neuspera Raises $26 Million in B Round, Led by China's 6 Dimensions

Neuspera Medical, a California neuromodulation company, completed the initial closing of a $26 million Series B round, led by 6 Dimensions Capital. 6 Dimensions was formed in 2017 by the merger of two China-US healthcare investors, Frontline BioVentures and WuXi Healthcare Ventures. Neuspera engineers miniaturized neuromodulation devices using both licensed and proprietary power transfer technologies. Neuspera's implanted modules are as much as 100 times smaller than its competition, the company says. More details.... Share this with colleagues: // //